Immune monitoring in cancer immunotherapy. by Romero, P, Pittet, M, Valmori, D, Speiser, D, Cerundolo, V, Liénard, D, Lejeune, F, Cerottini, J

An antigen-targeted approach to adoptive transfer therapy of cancer. by Valmori, D, Pittet, M, Rimoldi, D, Liénard, D, Dunbar, R, Cerundolo, V, Lejeune, F, Cerottini, J, Romero, P

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patient... by Speiser, D, Valmori, D, Rimoldi, D, Pittet, M, Liénard, D, Cerundolo, V, MacDonald, H, Cerottini, J, Romero, P

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. by Valmori, D, Dutoit, V, Liénard, D, Lejeune, F, Speiser, D, Rimoldi, D, Cerundolo, V, Dietrich, P, Cerottini, J, Romero, P

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. by Romero, P, Dunbar, P, Valmori, D, Pittet, M, Ogg, G, Rimoldi, D, Chen, J, Liénard, D, Cerottini, J, Cerundolo, V

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. by Valmori, D, Pittet, M, Vonarbourg, C, Rimoldi, D, Liénard, D, Speiser, D, Dunbar, R, Cerundolo, V, Cerottini, J, Romero, P

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue. by Valmori, D, Lévy, F, Miconnet, I, Zajac, P, Spagnoli, G, Rimoldi, D, Liénard, D, Cerundolo, V, Cerottini, J, Romero, P

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals. by Pittet, M, Valmori, D, Dunbar, P, Speiser, D, Liénard, D, Lejeune, F, Fleischhauer, K, Cerundolo, V, Cerottini, J, Romero, P

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes. by Speiser, D, Pittet, M, Valmori, D, Dunbar, R, Rimoldi, D, Liénard, D, MacDonald, H, Cerottini, J, Cerundolo, V, Romero, P

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues. by Valmori, D, Fonteneau, J, Valitutti, S, Gervois, N, Dunbar, R, Liénard, D, Rimoldi, D, Cerundolo, V, Jotereau, F, Cerottini, J, Speiser, D, Romero, P